AstraZeneca has been engulfed by concerns and criticism of its COVID-19 vaccine collaboration with Oxford University in recent weeks, but CEO Pascal Soriot maintained calm at the eye of the storm during the company’s Q4 and full year results.
AZ Brushes Off Vaccine Criticism, Awaits US Readout
WHO Endorsement Counters Fears
While fast-developing news on COVID-19 is grabbing the headlines, oncology will continue to drive growth in 2021.
